For: | Sapisochin G, Sevilla EF, Echeverri J, Charco R. Management of “very early” hepatocellular carcinoma on cirrhotic patients. World J Hepatol 2014; 6(11): 766-775 [PMID: 25429314 DOI: 10.4254/wjh.v6.i11.766] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v6/i11/766.htm |
Number | Citing Articles |
1 |
Fei Xue, Yuntian Liang, Zhenrong Li, Yanhui Liu, Hongwei Zhang, Yu Wen, Lei Yan, Qiang Tang, Erhui Xiao, Dongyi Zhang. MicroRNA‑9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A‑2. Oncology Letters 2017; doi: 10.3892/ol.2017.7399
|
2 |
Gonzalo Sapisochín, Elena Fernández de Sevilla, Juan Echeverri, Ramón Charco. Liver transplantation for cholangiocarcinoma: Current status and new insights. World Journal of Hepatology 2015; 7(22): 2396-2403 doi: 10.4254/wjh.v7.i22.2396
|
3 |
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, Shahid A. Khan, Alex Loukas, Alphonse E. Sirica, Bin Tean Teh, Sopit Wongkham, Gregory J. Gores. Cholangiocarcinoma. Nature Reviews Disease Primers 2021; 7(1) doi: 10.1038/s41572-021-00300-2
|
4 |
Mahmoud A. Dawoud, Rania E. Mohamed, Mohamed S. El Waraki, Ahmed M. Gabr. Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(4): 935 doi: 10.1016/j.ejrnm.2017.06.005
|
5 |
Hongyan Fan, Chenggang Zhou, Jianzhou Yan, Weihua Meng, Wenquan Zhang. Treatment of solitary hepatocellular carcinoma up to 2 cm. Medicine 2020; 99(23): e20321 doi: 10.1097/MD.0000000000020321
|
6 |
Qiushuang Xiong, Shaoshuai Wu, Jingwen Wang, Xianhuang Zeng, Jianwen Chen, Mingcong Wei, Haotong Guan, Chengpeng Fan, Lang Chen, Deyin Guo, Guihong Sun. Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression. Cell & Bioscience 2017; 7(1) doi: 10.1186/s13578-017-0144-8
|
7 |
Abdullah Esmail, Mohamed Badheeb, Batool Alnahar, Bushray Almiqlash, Yara Sakr, Bayan Khasawneh, Ebtesam Al-Najjar, Hadeel Al-Rawi, Ala Abudayyeh, Yaser Rayyan, Maen Abdelrahim. Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation. Cancers 2024; 16(11): 1946 doi: 10.3390/cancers16111946
|
8 |
Nadine Soliman, Ashton A. Connor, Sudha Kodali, Rafik Mark Ghobrial. Liver Transplantation for Cholangiocarcinoma. Digestive Disease Interventions 2024; 8(04): 239 doi: 10.1055/s-0044-1787171
|
9 |
Hye‐Lin Kim, Jihyun An, Jae‐A Park, Seung‐Hoo Park, Young‐Suk Lim, Eui‐Kyung Lee. Magnetic Resonance Imaging Is Cost‐Effective for Hepatocellular Carcinoma Surveillance in High‐Risk Patients With Cirrhosis. Hepatology 2019; 69(4): 1599 doi: 10.1002/hep.30330
|
10 |
Panpan Li, Juanjuan Zhang, Fuchun Li, Yanyan Yu, Yinghong Chen. Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axis. International Journal of Molecular Medicine 2019; doi: 10.3892/ijmm.2019.4205
|
11 |
Ning Qi Pang, Albert C. Y. Chan, Alfred Wei Chieh Kow. Trends of liver transplantation in Asia. Updates in Surgery 2024; doi: 10.1007/s13304-024-01924-1
|
12 |
Susumu Eguchi, Masaaki Hidaka, Takanobu Hara, Hajime Matsushima, Akihiko Soyama. Liver transplantation for intrahepatic and hilar cholangiocellular carcinoma: Most recent updates in the literature. Annals of Gastroenterological Surgery 2022; 6(5): 616 doi: 10.1002/ags3.12567
|
13 |
Chen-Dan Zou, Wei-Ming Zhao, Xiao-Na Wang, Qiang Li, Hui Huang, Wan-Peng Cheng, Jian-Feng Jin, He Zhang, Ming-Juan Wu, Sheng Tai, Chao-Xia Zou, Xu Gao. MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma. Oncotarget 2016; 7(1): 266 doi: 10.18632/oncotarget.5689
|
14 |
Nadine Soliman, David W. Victor, Ashton Anthony Connor. Transplant Oncology. 2025; : 159 doi: 10.1016/B978-0-443-21901-6.00013-6
|
15 |
Wenzhe Si, Yang Zhao, Jiansuo Zhou, Qiang Zhang, Yuan Zhang. The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101. Experimental Cell Research 2019; 379(1): 1 doi: 10.1016/j.yexcr.2019.03.017
|
16 |
Alexander E. Hare, Mina S. Makary. Locoregional Approaches in Cholangiocarcinoma Treatment. Cancers 2022; 14(23): 5853 doi: 10.3390/cancers14235853
|
17 |
Soroosh Sabeti, Redouane Ternifi, Nicholas B. Larson, Michael C. Olson, Thomas D. Atwell, Mostafa Fatemi, Azra Alizad. Morphometric analysis of tumor microvessels for detection of hepatocellular carcinoma using contrast-free ultrasound imaging: A feasibility study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1121664
|
18 |
Tian’an Jiang, Linya Yu, Yilei Zhao, Baohua Wang. Artificial Liver. 2021; : 243 doi: 10.1007/978-981-15-5984-6_9
|
19 |
Guoliang Wang, Wei Zhang, Yifei Tan, Li Jiang, Jian Yang, Jiayin Yang, Lunan Yan. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection. International Journal of Surgery 2019; 72: 1 doi: 10.1016/j.ijsu.2019.10.006
|